RN7SL204P

Across TCGA pan-cancer cohorts, RN7SL204P RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated RN7SL204P data layer.

The strongest signal is observed in thymoma (THYM), where higher RN7SL204P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RN7SL204P expression acts as an unfavorable survival marker, although some lineages such as PRAD and STAD show a favorable association.

THYM, LUSC, and CHOL are the cancer types where RN7SL204P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THYM	DFS	Tertile	All	0.216	0.775	<.001	60	view →
LUSC	DFS	Tertile	All	0.338	0.729	<.001	36	view →
CHOL	DFS	Tertile	All	0.070	0.498	.006	36	view →
UCS	DFS	Tertile	IV	0.132	0.718	.002	36	view →
THCA	DFS	Tertile	All	0.793	0.905	.008	27	view →
PCPG	OS	Tertile	All	0.670	0.945	.010	18	view →
GBM	OS	Tertile	All	0.234	0.436	.033	9	view →
PRAD	OS	Tertile	All	0.902	0.886	.027	6	view →
SKCM	DFS	Tertile	All	0.082	0.242	.033	3	view →
STAD	OS	Quartile	II,III,IV	0.723	0.464	.045	3	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

RN7SL204P–THYM (DFS)

Open the THYM breakdown →